SETD2 and breast cancer: In hypoxic environments, breast cancer cells express high levels of HIF-1, which promotes the expression of CXC chemokine receptor 3 (CXCR3) and CXC chemokine receptor 5 (CXCR5) on breast cancer cell lines.